Viracta Therapeutics, Inc. (VIRX)
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.
Address
2533 S COAST HWY 101
CARDIFF, CA 92007
Founded
1998
Number of Employees
40
Website
http://www.viracta.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)